PMH5 INFLUENCE OF PSYCHIATRIC COMORBIDITY AND POLYPHARMACY ON HOSPITALIZATION AND EXPENDITURES AMONG SECOND GENERATION ANTIPSYCHOTIC USERS WITH METABOLIC SYNDROME
May 1, 2010, 00:00
10.1016/S1098-3015(10)72501-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)72501-8/fulltext
Title :
PMH5 INFLUENCE OF PSYCHIATRIC COMORBIDITY AND POLYPHARMACY ON HOSPITALIZATION AND EXPENDITURES AMONG SECOND GENERATION ANTIPSYCHOTIC USERS WITH METABOLIC SYNDROME
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72501-8&doi=10.1016/S1098-3015(10)72501-8
First page :
Section Title :
Open access? :
No
Section Order :
32